Всероссийская GMP-конференция | Pharmstandard

General partner


5B Likhachevsky proezd, Dolgoprudny town, Moscow Region, 141700
Tel.: +7 (495) 970 0030/32


Pharmstandard is a leading Russian pharmaceutical company, which priorities are development and manufacture of advanced, high-quality and affordable pharmaceutical products compliant with the Russian healthcare requirements and patients` needs.

 The pharmaceutical portfolio of the company includes pharmaceutical products for the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, metabolic disorders, oncology, gastroenterological and infectious diseases, neurological disorders and a variety of other diseases. The company supplies its products throughout all Russia and abroad.

The manufacturing capabilities of Pharmstandard are represented by 5 manufacturing sites, located in the city of Kursk (PHS-Leksredstva JSC), city of Ufa (Pharmstandard-Ufa JSC), city of Tomsk (PHS-Tomskhimpharm JSC), Volginsky settlement of Vladimir region (LECCO JSC), Petrovo-Dalnee settlement, Krasnogorsky District of Moscow Region (J.S.C. «Biomed»-Mechnikov). 

The organization of pharmaceutical production at the company’s manufacturing sites meets the requirements of the Good Manufacturing Practices. This is confirmed by GMP-certificates. At Phs-Leksredstva JSC 8 production areas are EU GMP-certified.

In 2018, Pharmstandard-Leksredstva JSC received the Russian Government Award for achievement of high product/service quality and introduction of highly effective methods of quality management.

According to the publication PharmVestnik, Pharmstandard has led the Rating of the Most Influential Pharmaceutical Market Entities, based on the results of 2018 (nomination «Russian manufacturer with the greatest impact on the pharmaceutical market in 2018»). Pharmstandard takes over the leadership of TOP-10 national pharmaceutical companies in the Influence rating year on year.